MedTrace Logo

Pilot Study of Whole Body Vibration for Children With Cerebral Palsy (CP) From 12 Months of Age

NCT01491152 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2014-03-07

No results posted yet for this study

Summary

Cerebral Palsy (CP) is the most common cause of physical disability in childhood. Up to day the investigators have treated children diagnosed cerebral palsy with side-alternating whole body vibration (System Galileo®) from the age of two years on. Considering verticalisation (standing and walking) at about 12 months of age in a normal developing child the investigators suggest the introduction of verticalisation with whole body vibration to a child with CP at this early age in order to enhance motor development and participation.

In this pilot study the investigators will test the feasibility and the effect on motor development of whole body vibration in children with CP from 12 months of age. The investigators will investigate the effect of whole body vibration on motor performance, independence in all day living situations, quality of life and contractures compared to a control group.

Conditions

  • Cerebral Palsy (CP)

Interventions

DEVICE

Galileo® tilt table for children

Two weeks of introduction and 12 weeks of training with side-alternating whole body vibration (WBV) (Galileo® tilt table)

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Christina Stark, MSc. · Children's Hospital University of Cologne

  • Peter Herkenrath, Dr. · Children's Hospital University of Cologne

  • Eckhard Schoenau, Prof. · Children's Hospital University of Cologne

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
12 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01491152 on ClinicalTrials.gov